Addex Therapeutics Ltd Stock
Stocks
ADXN
CH0029850754
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe Europe
05:13:09 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 0.0246 CHF | +3.36% |
|
+11.71% | -55.23% |
| 09-21 | Swiss stocks - Factors to watch on September 21 | RE |
| 08-26 | Addex Therapeutics Raises $3 Million via American Depositary Shares Offering | MT |
| Market Cap | 2.84M 3.44M 3.02M 2.6M 4.85M 330M 4.89M 34.11M 13.22M 168M 12.93M 12.64M 545M | P/E 2024 |
0.8x | P/E 2025 | -0.88x |
|---|---|---|---|---|---|
| Enterprise Value | 1.24M 1.5M 1.31M 1.13M 2.11M 143M 2.13M 14.84M 5.75M 73.16M 5.63M 5.5M 237M | EV / Sales 2024 |
5.67x | EV / Sales 2025 | 28.1x |
| Free-Float |
43.94% | Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| ADXN | Delayed | |
CBOE
| 0QNV | Real-time | |
|
Deutsche Boerse AG
| APE | Delayed | |
|
Börse Stuttgart
| APE | Delayed | |
|
Boerse Muenchen
| APE | Real-time |
Last Transcript: Addex Therapeutics Ltd
| 1 day | +0.84% | ||
| 1 week | +11.71% | ||
| Current month | -7.46% | ||
| 1 month | -11.43% | ||
| 3 months | -40.95% | ||
| 6 months | -34.74% | ||
| Current year | -55.23% |
| 1 week | 0.02 |  | 0.02 |
| 1 month | 0.02 | | 0.03 |
| Current year | 0.02 | | 0.07 |
| 1 year | 0.02 | | 0.07 |
| 3 years | 0.02 | | 0.26 |
| 5 years | 0.02 | | 1.5 |
| 10 years | 0.02 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tim Dyer
CEO | Chief Executive Officer | 58 | 2013-05-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 40 | 2017-05-31 |
Roger Mills
CTO | Chief Tech/Sci/R&D Officer | 69 | 2016-11-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Lawton
CHM | Chairman | 77 | - |
Tim Dyer
BRD | Director/Board Member | 58 | 2014-12-31 |
Ray Hill
BRD | Director/Board Member | 81 | 2010-05-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/2/26 | Issuer sale | Chief Technology Officer | -885,674 | 0.4051% | ||
| 9/2/26 | Issuer sale | Director | -539,122 | 0.2466% | ||
| 9/2/26 | Issuer sale | Chief Financial Officer | -1,205,816 | 0.5515% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.36% | +11.71% | -63.42% | -64.27% | 3.44M | |
| +0.50% | +3.16% | +7.17% | +30.11% | 47.56B | |
| -0.83% | -0.36% | +43.66% | +34.77% | 44.09B | |
| -0.84% | +4.86% | +10.92% | +91.52% | 41.5B | |
| -1.10% | -2.64% | +331.49% | +535.80% | 40.88B | |
| -0.62% | +0.11% | +1.12% | +46.02% | 29.67B | |
| -2.07% | +0.12% | +24.39% | +154.30% | 17.23B | |
| +1.39% | +0.62% | +24.98% | +41.32% | 15.06B | |
| -6.08% | -9.92% | - | - | 14.65B | |
| -0.78% | +9.46% | -8.96% | - | 13.82B | |
| Average | -1.00% | +1.25% | +41.26% | +108.70% | 26.45B | |
| Weighted average by Cap. | -0.87% | +0.96% | +67.96% | +141.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 410K 497K 436K 375K 701K 47.61M 706K 4.93M 1.91M 24.27M 1.87M 1.83M 78.7M | 173K 210K 184K 158K 295K 20.07M 298K 2.08M 805K 10.23M 787K 770K 33.18M |
| Net income | 7.06M 8.55M 7.51M 6.45M 12.05M 819M 12.14M 84.75M 32.86M 418M 32.12M 31.41M 1.35B | -6.73M -8.16M -7.16M -6.15M -11.49M -781M -11.58M -80.82M -31.33M -398M -30.62M -29.95M -1.29B |
| Net Debt | -3.3M -4M -3.51M -3.02M -5.64M -383M -5.68M -39.63M -15.37M -195M -15.02M -14.69M -633M | -1.6M -1.94M -1.71M -1.47M -2.74M -186M -2.76M -19.27M -7.47M -94.94M -7.3M -7.14M -308M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | CHF 0.0248 | +4.20% | 53,841 |
| 26-09-23 | CHF 0.0238 | +4.39% | 304,169 |
| 26-09-22 | CHF 0.0228 | +2.70% | 327,037 |
| 26-09-21 | CHF 0.0222 | 0.00% | 149,312 |
| 26-09-18 | CHF 0.0222 | 0.00% | 604,531 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ADXN Stock
Select your edition
All financial news and data tailored to specific country editions
